PedAM
Pediatric Disease Annotations & Medicines
| Disease | myocardial infarction |
| Phenotype | C0011847|diabetes |
| Sentences | 128 |
| PubMedID- 21417718 | Patients with diabetes show dysfunction of cms independent of myocardial infarction, indicating that diabetes directly affects cms. |
| PubMedID- 24386093 | Independent determinants of cardiovascular events (myocardial infarction, stroke, death) in patients with pad without diabetes mellitus. |
| PubMedID- 23403268 | In multivariate cox analyses adjusting for age, sex, race, diabetes mellitus, history of heart failure, myocardial infarction, ischemic heart disease, stroke, smoking, serum high-density lipoprotein cholesterol, creatinine, glucose, and urine albumin/creatinine ratio as standard risk factors, and for incident myocardial infarction, in-treatment use of digoxin, systolic and diastolic pressure, heart rate, qrs duration, cornell voltage-duration product, and sokolow-lyon voltage left ventricular hypertrophy treated as time-varying covariates, new-onset af remained associated with a >3-fold increased risk of scd (hazard ratio, 3.13; 95% confidence interval, 1.87-5.24; p<0.001). |
| PubMedID- 23117562 | We examined levels and trends in cardiovascular risk factors and drug treatment in myocardial infarction (mi) patients with and without diabetes: 4837 patients with mi, out of which 1014 had type 2 diabetes and 3823 had no diabetes. |
| PubMedID- 24229770 | Although pioglitazone significantly prevented the progression of coronary atherosclerosis and reduced the recurrence of myocardial infarction in patients with type 2 diabetes mellitus (dm), it remains unclear whether pioglitazone could attenuate coronary artery inflammation. |
| PubMedID- 20009093 | Rapid identification of myocardial infarction risk associated with diabetes medications using electronic medical records. |
| PubMedID- 23674307 | Our main objective was to evaluate the association between intensive statin therapy and new-onset diabetes mellitus in patients with myocardial infarction and to evaluate the association of intensive statin therapy with long-term adverse clinical outcomes. |
| PubMedID- 21907990 | We investigated whether snp rs4788102, which captures the entire sh2b1 variability, is associated with coronary artery disease (cad) and/or myocardial infarction (mi) in patients with type 2 diabetes mellitus (t2dm). |
| PubMedID- 20431807 | 30 type 2 diabetes mellitus cases with myocardial infarction and equal members of type 2 diabetics without complications are enrolled. |
| PubMedID- 22279115 | Although the 7% prevalence of diabetes among patients with myocardial infarction is substantially lower than in other western countries,2 it is only slightly lower than reported in the second danish trial on acute myocardial infarction (danami-2) (11%).28 also, because the comparisons were made within a population of patients with myocardial infarction, underascertainment of comorbidities is unlikely to influence substantially the relative mortality estimates associated with comorbidity categories. |
| PubMedID- 24708579 | Pioglitazone also reduced the risk of hospitalization for acute myocardial infarction in patients with type 2 diabetes in comparison with rosiglitazone [16,17]. |
| PubMedID- 24773097 | Incremental costs associated with myocardial infarction and stroke in patients with type 2 diabetes mellitus: an overview for economic modeling. |
| PubMedID- 22611064 | A dysfunction of autonomic nervous system has been associated with increased mortality after myocardial infarction (13,14) in patients with diabetes (15,16) and in the general population (17). |
| PubMedID- 26331054 | It is only now being appreciated that aki survivors have similar long-term outcomes as patients with diabetes and survivors of a st-elevation myocardial infarction [107, 108]. |
| PubMedID- 26445676 | In addition, patients who survive aki have worse long-term outcomes than patients with diabetes mellitus and survivors of an st-elevation myocardial infarction [4, 5]. |
| PubMedID- 24552888 | In multivariable cox analyses adjusting for randomized treatment, age, sex, diabetes, history of heart failure, myocardial infarction, ischemic heart disease, stroke, peripheral vascular disease, smoking status, baseline body mass index, serum total and high-density lipoprotein cholesterol, creatinine, glucose, and urine albumin/creatinine ratio as standard risk factors, and for incident myocardial infarction, in-treatment heart rate, systolic and diastolic pressure, cornell product, and sokolow-lyon voltage lvh treated as time-varying covariables, black race remained associated with a 45% decreased risk of developing new af (hr = 0.55; 95% ci = 0.35-0.87; p = 0.01). |
| PubMedID- 25860211 | Most prevalent were hypertension, coronary artery disease, diabetes, and previous history of myocardial infarction (table 1). |
| PubMedID- 20700422 | Pioglitazone is associated with a lower risk of death, myocardial infarction, and stroke in patients with diabetes [36]. |
| PubMedID- 26341185 | Comparison of changes in global longitudinal peak systolic strain after st-segment elevation myocardial infarction in patients with versus without diabetes mellitus. |
| PubMedID- 25879728 | Moreover, diabetes with prior myocardial infarction had much higher cardiovascular mortality (45%) than non diabetes with prior myocardial infarction (mi) (18.8%) [2]. |
| PubMedID- 22247906 | Patients with type 2 diabetes without a history of myocardial infarction are regarded to have the same risk of a coronary event as patients without diabetes who have a history of myocardial infarction [6]. |
| PubMedID- 21357366 | In addition, another recent prospective study conducted in spain found a hazard ratio of 0.33 for fatal or nonfatal myocardial infarction in individuals with type 2 diabetes compared with nondiabetic individuals with a prior myocardial infarction (11). |
| PubMedID- 22403651 | Ors are adjusted for age, body mass index, educational level, hypertension, hypercholesterolemia, diabetes, history of myocardial infarction and stroke. |
| PubMedID- 25671950 | The objective of study was to determine the frequency of newly diagnosis diabetes presenting with acute myocardial infarction. |
| PubMedID- 22783203 | In these analyses, we regarded the following data as covariates for multivariate analysis: age category (70–74, 75–79, 80–84 years); sex; bmi (continuous variable); hypertension, hypercholesterolemia, diabetes mellitus, history of stroke, myocardial infarction, or angina pectoris, liver diseases, renal diseases (presence or absence); cognitive function (mini-mental state examination score of <24 or ≥24); depressive symptoms (geriatric depression scale scores of <11 or ≥11); smoking (never, former, and current smoker); use of alcohol (never, former, and currently drinking); use of tranquilizer (yes or no); physical functioning status (mos scores [continuous variables]); leisure-time physical activity (level 1: no sports, no brisk walking, no walking; level 2: no sports, no brisk walking; low amount of walking; level 3: no sports, no brisk walking, high amount of walking; level 4: no sports, low amount of brisk walking, any amount of walking; level 5: no sports, high amount of brisk walking, any amount of walking; level 6: any amount of sports, any amounts of brisk walking, any amount of walking). |
| PubMedID- 25297571 | Aims/hypothesis: diabetes increases the risk of acute myocardial infarction (ami) and effective means for primary prevention are warranted. |
| PubMedID- 21576196 | An increased incidence of myocardial infarction with rosiglitazone in patients with type 2 diabetes mellitus (t2dm) has been reported. |
| PubMedID- 22717317 | The rate of incident myocardial infarction in people with diabetes was substantially lower than for those with chronic kidney disease when defined by egfr of less than 45 ml/min per 1.73 m(2) and severely increased proteinuria (6.6 per 1000 person-years, 6.4-6.9 vs 12.4 per 1000 person-years, 9.7-15.9). |
| PubMedID- 24422205 | Age+previous and current smoking, waist circumference, systolic blood pressure, triglycerides, ldl cholesterol, diabetes, family history of myocardial infarction, total cholesterol and use of statins. |
| PubMedID- 26410961 | Hyperleptinemia and its relationship with myocardial necrosis markers (creatine phosphokinase, creatine phosphokinase-mb, troponin) give reason to suggest the important role of leptin in the development of inflammatory process associated with myocardial infarction in patients with and without diabetes mellitus. |
| PubMedID- 22377967 | Risk of ventricular arrhythmias after myocardial infarction with diabetes associated with sympathetic neural remodeling in rabbits. |
| PubMedID- 22679279 | Relationship between angiotensin-converting enzyme gene insertion/deletion polymorphism, angiographically defined coronary artery disease and myocardial infarction in patients with type 2 diabetes mellitus. |
| PubMedID- 26301192 | diabetes patients usually die of stroke, myocardial infarction, etc., and complications such as amputation of feet, blindness, renal failure, etc., seriously dampens the patients' quality of life and add economic burdens due to treatments [11121314]. |
| PubMedID- 22343257 | Background: the impact of diabetes in patients with acute myocardial infarction (ami) treated with primary percutaneous coronary intervention (pci) is unclear. |
| PubMedID- 21238901 | Impact of diabetes on outcome in patients with non-st-elevation myocardial infarction. |
| PubMedID- 23960432 | We are intrigued this study conducted as a student project for 3 months, with strict criteria excluding patients with systolic blood pressure >170 mmhg and <100 mmhg, diabetes mellitus, past history of myocardial infarction, renal impairment, hepatic impairment, cerebrovascular event, moderate to severe heart failure, bradycardia, second to third degree heart block, arrhythmias, history of drug intake namely diltiazem, verapamil, beta blockers, simvastatin, digoxin, amiodarone, phenytoin etc., could still manage to recruit a sizeable number of patients for such a short period. |
| PubMedID- 22567531 | Compared with patients with e′ ≥ 5.8 cm/s, those with e′ < 5.8 cm/s were more likely to be older, to have diabetes and history of myocardial infarction, to be prescribed angiotensin converting enzyme inhibitors/angiotensin receptor blockers, and to undergo coronary revascularization after the index cardiac catheterization and were less likely to be prescribed calcium blockers. |
| PubMedID- 20517158 | Conclusion: in acute st-segment elevation myocardial infarction patients without earlier known diabetes submitted to mechanical revascularization, the poorer in-hospital glucose control was associated with higher mortality; peak glycemia greater than 180 mg/dl was associated with the highest mortality, whereas patients with peak glycemia comprised between 140 and 180 mg/dl exhibited intermediate mortality rates. |
| PubMedID- 23108517 | Baseline characteristics, such as age, gender, diabetes mellitus, history of previous myocardial infarction, killip class on admission and ecg pattern (including information regarding any bundle branch blocks – old, new or of unknown origin) were analysed. |
| PubMedID- 20442057 | Residential proximity to environmental sources of persistent organic pollutants and first-time hospitalizations for myocardial infarction with comorbid diabetes mellitus: a 12-year population-based study. |
| PubMedID- 24348585 | This is confirmed by the lack of any effect of glucose-insulin infusions in the acute phase of myocardial infarction in patients without diabetes (39). |
| PubMedID- 20640879 | In men, serum cholesterol level and high-density lipoprotein level, diabetes mellitus and history of myocardial infarction were key risk factors for chd. |
| PubMedID- 24254885 | However, they do not constitute sufficient evidence to indicate the routine use of chelation therapy for all post-myocardial infarction patients with diabetes mellitus. |
| PubMedID- 23225175 | The second trial, the cardiovascular inflammation reduction trial (cirt) has been funded by the national heart, lung, and blood institute (nhlbi) and will evaluate whether low dose methotrexate (target dose 20 mg/week) as compared to placebo will reduce major vascular events among a group of post-myocardial infarction patients with either diabetes or metabolic syndrome, groups known to have high risk on the basis of a persistent pro-inflammatory response. |
| PubMedID- 20465096 | The risk of myocardial infarction in patients with type 2 diabetes is 3-5 times higher than in non-diabetics. |
| PubMedID- 21747831 | Exercise microvolt t-wave alternans identify sudden cardiac death risk and have been identified in the ecgs of postmyocardial infarction patients with diabetes [26]. |
| PubMedID- 21709632 | Importantly, cardiovascular outcome studies further suggested that pioglitazone reduced all-cause mortality, myocardial infarction, and stroke in patients with type 2 diabetes [24,48]. |
| PubMedID- 23915139 | Achieving early glycemic control in patients with newly diagnosed diabetes reduces the risk of microvascular complications, myocardial infarction, and all-cause mortality [18]. |
| PubMedID- 22264268 | This relationship held true even after adjusting for age, gender, diabetes, hypertension, history of myocardial infarction or stroke, smoking status, and region of the country. |
| PubMedID- 26115092 | In conclusion, this nationwide, population-based cohort study demonstrated that in type 2 diabetes patients with recent myocardial infarction, the use of sitagliptin is not associated with increased risk of composite adverse cardiovascular outcomes, including myocardial infarction, ischemic stroke, and cardiovascular death. |